Clinical effectiveness and components of Home-pulmonary rehabilitation for people with chronic respiratory diseases: A systematic review protocol

Introduction Chronic respiratory diseases (CRDs) are common and disabling conditions that can result in social isolation and economic hardship for patients and their families. Pulmonary rehabilitation (PR) improves functional exercise capacity and health-related quality of life (HRQoL) but practical...

Full description

Bibliographic Details
Published in:BMJ Open
Main Author: Uzzaman M.N.; Chan S.C.; Shunmugam R.H.; Engkasan J.P.; Agarwal D.; Habib G.M.M.; Hanafi N.S.; Jackson T.; Jebaraj P.; Khoo E.M.; Liew S.M.; Mirza F.T.; Pinnock H.; Rabinovich R.A.
Format: Article
Language:English
Published: BMJ Publishing Group 2021
Online Access:https://www.scopus.com/inward/record.uri?eid=2-s2.0-85117485774&doi=10.1136%2fbmjopen-2021-050362&partnerID=40&md5=62cffabc99143896706e25c4501efb07
Description
Summary:Introduction Chronic respiratory diseases (CRDs) are common and disabling conditions that can result in social isolation and economic hardship for patients and their families. Pulmonary rehabilitation (PR) improves functional exercise capacity and health-related quality of life (HRQoL) but practical barriers to attending centre-based sessions or the need for infection control limits accessibility. Home-PR offers a potential solution that may improve access. We aim to systematically review the clinical effectiveness, completion rates and components of Home-PR for people with CRDs compared with Centre-PR or Usual care. Methods and analysis We will search PubMed, CINAHL, Cochrane, EMBASE, PeDRO and PsycInfo from January 1990 to date using a PICOS search strategy (Population: adults with CRDs; Intervention: Home-PR; Comparator: Centre-PR/Usual care; Outcomes: functional exercise capacity and HRQoL; Setting: any setting). The strategy is to search for € Chronic Respiratory Disease' AND € Pulmonary Rehabilitation' AND € Home-PR', and identify relevant randomised controlled trials and controlled clinical trials. Six reviewers working in pairs will independently screen articles for eligibility and extract data from those fulfilling the inclusion criteria. We will use the Cochrane risk-of-bias tool and Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to rate the quality of evidence. We will perform meta-analysis or narrative synthesis as appropriate to answer our three research questions: (1) what is the effectiveness of Home-PR compared with Centre-PR or Usual care? (2) what components are used in effective Home-PR studies? and (3) what is the completion rate of Home-PR compared with Centre-PR? Ethics and dissemination Research ethics approval is not required since the study will review only published data. The findings will be disseminated through publication in a peer-reviewed journal and presentation in conferences. PROSPERO registration number CRD42020220137. ©
ISSN:20446055
DOI:10.1136/bmjopen-2021-050362